A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
Clinical trial NCT01212991 · COMPLETED
Trial details
- NCT number
- NCT01212991
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-16
- Primary completion
- 2013-09-30
- Enrollment
- 1717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.